Post-Operative Adjuvant Interferon Alpha 2 in Resected High-Risk Primary and Regionally Metastatic Melanoma

Implications of microscopic satellites of the primary and extracapsular lymph node spread in patients with high-risk melanoma: pathologic corollary of Eastern Cooperative Oncology Group Trial E1690

UNM Rao;J Ibrahim;LE Flaherty;J Richards;JM Kirkwood Journal of Clinical Oncology 20(8):2053-2057

Bayesian cure rate models for malignant melanoma: a case-study of Eastern Cooperative Oncology Group trial E1690

MH Chen;DP Harrington;JG Ibrahim Applied Statistics 51(part.2):135-150

Letter to the editor: Interferon alfa-2a for melanoma metastases

Jm Kirkwood;JG Ibrahim;VK Sondak;MS Ernstoff;M Ross The Lancet 359:978-979

Pooled-analysis of four ECOG/Intergroup trials of high-dose interferon alfa-2b (HDI) in 1916 patients with high-risk resected cutaneous melanoma.

JM Kirkwood;J Manola;J Ibrahim;VK Sondak;MS Ernstoff Proc of the American Society of Clinical Oncology 20:350a(#1395)

High-and low-dose interferon alfa-2b in high-risk melanoma: first analysis of Intergroup trial E1690/S9111/C9190

JM Kirkwood;J Ibrahim;VK Sondak;J Richards;LE Flaherty;MS Ernstoff;TJ Smith;U Rao;M Steele;RH Blum Journal of Clinical Oncology 18(12):2444-2458

Overview of the role of high-dose IFN (2b(HDI) in the therapy of high-risk resectable melanoma.

JM Kirkwood;JA Sosman;MS Ernstoff;MA Ross;SS Aggarawal;HF Edington Journal of Immunotherapy 23(5):595

Preliminary analysis of the E1690/S9111/C9190 intergroup postoperative adjuvant trial of high-and low- dose IFNa2b (HDI and LDI) in high-risk primary or lymph node metastatic melanoma.

JM Kirkwood;J Ibrahim;V Sondak;M Ernstoff;L Flaherty;T Smith;J Richards;U Rao;M Steele;R Blum Proc of the American Society of Clinical Oncology 18:537a(#2072)

Adjuvant therapy for melanoma.

VK Sondak;JA Wolfe Current Opinion in Oncology 9:189-204

Direct visualization of the clonal progression of primary cutaneous melanoma: Application of tissue microdissectio and comparative genomic hybridization.

RN Wiltshire;P Duray;ML Bittner;T Visakorpi;PS Meltzer;RJ Tuthill;LA Liotta;JM Trent Cancer Research 55:3954-3957